|
|
|
| home > white papers > Crossing the Blood Brain Barrier (BBB): Which Route to Take? - Aptar Pharma |
|
|
 WHITE PAPERS |
|
Aptar Pharma
|
|
Crossing the Blood Brain Barrier (BBB): Which Route to Take?
|
|
Aptar Pharma recently hosted an expert panel/roundtable on the various
approaches to treating central nervous system (CNS) diseases. This
international scientific forum was held in Paris, France on December
5th, 2014. The roundtable was organized to explore and exchange views on
the challenges, approaches and opportunities that exist with regard to
effectively crossing the blood brain barrier (BBB) and successfully
treating a host of CNS diseases.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations
Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >> |
|
 |
White Papers |
 |
|
Convergence in the Pharmaceutical Market
PCI Pharma Services
Convergence is currently playing a large part in the growth of the pharmaceutical market. The need for convergence is due to many factors including the declining economy and high competition within the sector. There are many convergences within this sector to date; these include the convergence of food based products with medical and health products and the convergence of prescription drugs to over the counter (OTC) products. Although convergence is helping the pharmaceutical industry expand and develop, it also poses some challenges; these include the regulatory outlook and counterfeiting.
More info >> |
|
 |
Industry Events |
 |
CPhI & P-MEC China
18-20 June 2019, SNIEC, Shanghai, China
CPhI & P-MEC China 2019 is your gateway to successfully grow your business at the 2nd largest pharma market in the world. Whether you are looking for sourcing new business or getting the latest market insight, this is your one-stop shop pharmaceutical platform in Asia.
More info >> |
|
|
|
